Operating Lease, Right-of-Use Asset of Cordyceps Sunshine Biotech Holdings Co., Ltd. from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $99,328, a 49% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$99,328	-$96,447	-49%	31 Dec 2024	20-F	13 Jun 2025	2024	FY
Q4 2023	$195,775	+$17,609	+9.9%	31 Dec 2023	20-F/A	23 Sep 2025	2023	FY
Q4 2022	$178,166			31 Dec 2022	20-F/A	23 Sep 2025	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.